Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Detournay

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
International Journal of Public Health|November 27, 2010
A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancerNadia Demarteau, Bruno Detournay, Bertrand Tehard, et al.
International Journal of Public Health|June 29, 2011
Public health impact of human papillomavirus vaccination on prevention of cervical cancer in FranceAbdelkader El Hasnaoui, Nadia Demarteau, Denis Granados, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|July 25, 2017
[Self-monitoring of blood glucose in France: data from a national survey]Bruno Guerci, Pierre-Yves Benhamou, Danièle Durain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2016
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims StudyRonan Roussel, Bernard Charbonnel, Mourad Behar, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 12, 2020
Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 DiabetesRonan Roussel, Bruno Detournay, Zahra Boultif, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2020
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance DatabaseCorinne Emery, Elodie Torreton, Sylvie Dejager, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 15, 2014
Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA StudyDominique Simon, Bruno Detournay, Evelyne Eschwege, et al.
Journal of Medical Screening|March 28, 2023
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testingAgathe Marchadier, Laura Bezannier, Stéphanie Barré-Pierrel, et al.
Diabetes Care|September 29, 2004
A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) studyIbrahim Salti, Eric Bénard, Bruno Detournay, et al.
Pharmacoeconomics - Open|April 7, 2018
Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database AnalysisBernard Charbonnel, Dominique Simon, Jean Dallongeville, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Public Health|November 27, 2010
A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancerNadia Demarteau, Bruno Detournay, Bertrand Tehard, et al.
International Journal of Public Health|June 29, 2011
Public health impact of human papillomavirus vaccination on prevention of cervical cancer in FranceAbdelkader El Hasnaoui, Nadia Demarteau, Denis Granados, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|July 25, 2017
[Self-monitoring of blood glucose in France: data from a national survey]Bruno Guerci, Pierre-Yves Benhamou, Danièle Durain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2016
Persistence with Insulin Therapy in Patients with Type 2 Diabetes in France: An Insurance Claims StudyRonan Roussel, Bernard Charbonnel, Mourad Behar, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 12, 2020
Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 DiabetesRonan Roussel, Bruno Detournay, Zahra Boultif, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2020
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance DatabaseCorinne Emery, Elodie Torreton, Sylvie Dejager, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 15, 2014
Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA StudyDominique Simon, Bruno Detournay, Evelyne Eschwege, et al.
Journal of Medical Screening|March 28, 2023
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testingAgathe Marchadier, Laura Bezannier, Stéphanie Barré-Pierrel, et al.
Diabetes Care|September 29, 2004
A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) studyIbrahim Salti, Eric Bénard, Bruno Detournay, et al.
Pharmacoeconomics - Open|April 7, 2018
Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database AnalysisBernard Charbonnel, Dominique Simon, Jean Dallongeville, et al.
Pageof 6